{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:11:31Z","timestamp":1751602291966,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["365358","HB3-164066"],"award-info":[{"award-number":["365358","HB3-164066"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["2P30 AI036219-26A, 5P30DA054557"],"award-info":[{"award-number":["2P30 AI036219-26A, 5P30DA054557"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["IN-CA-276-4012"],"award-info":[{"award-number":["IN-CA-276-4012"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61426-5","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:39:27Z","timestamp":1751564367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of doxycycline pre-exposure prophylaxis (doxyPrEP) for sexually transmitted infections on the microbiome of men who have sex with men on HIV PrEP"],"prefix":"10.1038","volume":"16","author":[{"given":"Samantha","family":"Knodel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leighanne","family":"Main","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon","family":"DeLeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Edward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Noel-Romas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-6513","authenticated-orcid":false,"given":"Troy","family":"Grennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"Burgener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"61426_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley, J. et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull. World Health Organ 97, 548\u2013562P (2019).","journal-title":"Bull. World Health Organ"},{"key":"61426_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4831-4","volume":"20","author":"K Jansen","year":"2020","unstructured":"Jansen, K. et al. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. BMC Infect. Dis. 20, 110 (2020).","journal-title":"BMC Infect. Dis."},{"key":"61426_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","volume":"18","author":"JM Molina","year":"2018","unstructured":"Molina, J. M. et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect. Dis. 18, 308\u2013317 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"61426_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","volume":"388","author":"AF Luetkemeyer","year":"2023","unstructured":"Luetkemeyer, A. F. et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N. Engl. J. Med 388, 1296\u20131306 (2023).","journal-title":"N. Engl. J. Med"},{"key":"61426_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","volume":"24","author":"JM Molina","year":"2024","unstructured":"Molina, J. M. et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 x 2 factorial design. Lancet Infect. Dis. 24, 1093\u20131104 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"61426_CR6","doi-asserted-by":"crossref","unstructured":"Traeger, M. W. et al. Doxycycline postexposure prophylaxis and bacterial sexually transmitted infections among individuals using HIV Preexposure prophylaxis. JAMA Intern. Med. 185, 273\u2013281 (2025).","DOI":"10.1001\/jamainternmed.2024.7186"},{"key":"61426_CR7","doi-asserted-by":"crossref","unstructured":"Sankaran, M. et al. Doxycycline postexposure prophylaxis and sexually transmitted infection trends. JAMA Intern. Med. 185, 266\u2013272 (2025).","DOI":"10.1001\/jamainternmed.2024.7178"},{"key":"61426_CR8","unstructured":"Grennan T, T. D. et al. Presented at: 25th International AIDS Conference. (Munich, Germany, 2024)."},{"key":"61426_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","volume":"42","author":"RK Bolan","year":"2015","unstructured":"Bolan, R. K. et al. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex. Transm. Dis. 42, 98\u2013103 (2015).","journal-title":"Sex. Transm. Dis."},{"key":"61426_CR10","doi-asserted-by":"crossref","unstructured":"Grennan, T. et al. A pilot, randomized controlled trial of Dual Daily HIV and sexually transmitted infection pre-exposure prophylaxis using tenofovir disoproxil fumarate\/emtricitabine and doxycycline in gay, bisexual and other men who have sex with men and transgender women: the DuDHS Study. Clin. Infect. Dis. 30, ciaf043 (2025).","DOI":"10.1093\/cid\/ciaf043"},{"key":"61426_CR11","first-page":"553","volume":"73","author":"H Peyriere","year":"2018","unstructured":"Peyriere, H., Makinson, A., Marchandin, H. & Reynes, J. Doxycycline in the management of sexually transmitted infections. J. Antimicrob. Chemother. 73, 553\u2013563 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"61426_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","volume":"73","author":"LH Bachmann","year":"2024","unstructured":"Bachmann, L. H. et al. CDC Clinical Guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recomm. Rep. 73, 1\u20138 (2024).","journal-title":"MMWR Recomm. Rep."},{"key":"61426_CR13","doi-asserted-by":"crossref","unstructured":"Gravett, R. M. et al. Preferences for monthly oral PrEP over other PrEP modalities among a national sample of gay, bisexual, and other men who have sex with men in the United States. J. Acquir. Immune Defic. Syndr. 99, 128\u2013137 (2025).","DOI":"10.1097\/QAI.0000000000003651"},{"key":"61426_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/OLQ.0000000000001130","volume":"47","author":"L Fusca","year":"2020","unstructured":"Fusca, L. et al. High interest in syphilis pre-exposure and post-exposure prophylaxis among gay, bisexual and other men who have sex with men in Vancouver and Toronto. Sex. Transm. Dis. 47, 224\u2013231 (2020).","journal-title":"Sex. Transm. Dis."},{"key":"61426_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jama.2023.16416","volume":"330","author":"KH Mayer","year":"2023","unstructured":"Mayer, K. H., Traeger, M. & Marcus, J. L. Doxycycline postexposure prophylaxis and sexually transmitted infections. JAMA 330, 1381\u20131382 (2023).","journal-title":"JAMA"},{"key":"61426_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121\u2013141 (2014).","journal-title":"Cell"},{"key":"61426_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S2213-2600(20)30052-7","volume":"8","author":"DM Patrick","year":"2020","unstructured":"Patrick, D. M. et al. Decreasing antibiotic use, the gut microbiota, and asthma incidence in children: evidence from population-based and prospective cohort studies. Lancet Respir. Med. 8, 1094\u20131105 (2020).","journal-title":"Lancet Respir. Med."},{"key":"61426_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00782-x","volume":"12","author":"DJ Schwartz","year":"2020","unstructured":"Schwartz, D. J., Langdon, A. E. & Dantas, G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med. 12, 82 (2020).","journal-title":"Genome Med."},{"key":"61426_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/cix833","volume":"66","author":"R Tariq","year":"2018","unstructured":"Tariq, R. et al. Low risk of primary clostridium difficile infection with tetracyclines: a systematic review and metaanalysis. Clin. Infect. Dis. 66, 514\u2013522 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"61426_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.20411\/pai.v7i1.512","volume":"7","author":"D Xu","year":"2022","unstructured":"Xu, D. et al. Why does doxycycline pose a relatively low risk for promotion of clostridioides difficile infection?. Pathog. Immun. 7, 81\u201394 (2022).","journal-title":"Pathog. Immun."},{"key":"61426_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2150452","volume":"14","author":"JE Buddle","year":"2023","unstructured":"Buddle, J. E. & Fagan, R. P. Pathogenicity and virulence of Clostridioides difficile. Virulence 14, 2150452 (2023).","journal-title":"Virulence"},{"key":"61426_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijantimicag.2006.09.020","volume":"29","author":"M Saarela","year":"2007","unstructured":"Saarela, M. et al. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic\/probiotic intervention. Int. J. Antimicrob. Agents 29, 271\u2013280 (2007).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"61426_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yrtph.2018.09.013","volume":"99","author":"Y Ahn","year":"2018","unstructured":"Ahn, Y. et al. In vitro test systems to determine tetracycline residue binding to human feces. Regul. Toxicol. Pharm. 99, 105\u2013115 (2018).","journal-title":"Regul. Toxicol. Pharm."},{"key":"61426_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.901911","volume":"13","author":"IB Moura","year":"2022","unstructured":"Moura, I. B. et al. Profiling the effects of systemic antibiotics for acne, including the narrow-spectrum antibiotic sarecycline, on the human gut microbiota. Front. Microbiol. 13, 901911 (2022).","journal-title":"Front. Microbiol."},{"key":"61426_CR25","doi-asserted-by":"crossref","unstructured":"Chu, V. T. et al. Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome. Nat. Med. 31, 207\u2013217 (2024).","DOI":"10.1038\/s41591-024-03274-2"},{"key":"61426_CR26","doi-asserted-by":"crossref","unstructured":"Grennan, T.M.S. et al. A pilot, randomized controlled trial of Dual Daily HIV and sexually transmitted infection pre-exposure prophylaxis using tenofovir disoproxil fumarate\/emtricitabine and doxycycline in gay, bisexual and other men who have sex with men and transgender women: the DuDHS study. Clin Infect Dis In press (2025).","DOI":"10.1093\/cid\/ciaf043"},{"key":"61426_CR27","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences (2nd ed.). (Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers., 1988)."},{"key":"61426_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28034-z","volume":"13","author":"JT Nearing","year":"2022","unstructured":"Nearing, J. T. et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat. Commun. 13, 342 (2022).","journal-title":"Nat. Commun."},{"key":"61426_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/QAD.0000000000002829","volume":"35","author":"H Gebrebrhan","year":"2021","unstructured":"Gebrebrhan, H. et al. Rectal microbiota diversity in Kenyan MSM is inversely associated with frequency of receptive anal sex, independent of HIV status. AIDS 35, 1091\u20131101 (2021).","journal-title":"AIDS"},{"key":"61426_CR30","doi-asserted-by":"publisher","first-page":"e1007611","DOI":"10.1371\/journal.ppat.1007611","volume":"15","author":"SX Li","year":"2019","unstructured":"Li, S. X. et al. Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection. PLoS Pathog. 15, e1007611 (2019).","journal-title":"PLoS Pathog."},{"key":"61426_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","volume":"5","author":"M Noguera-Julian","year":"2016","unstructured":"Noguera-Julian, M. et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine 5, 135\u2013146 (2016).","journal-title":"EBioMedicine"},{"key":"61426_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16222-8","volume":"11","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin, I. et al. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat. Commun. 11, 2448 (2020).","journal-title":"Nat. Commun."},{"key":"61426_CR33","doi-asserted-by":"crossref","unstructured":"Dillon, S. M. et al. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol. 9, 24\u201337 (2015).","DOI":"10.1038\/mi.2015.33"},{"key":"61426_CR34","doi-asserted-by":"crossref","unstructured":"Anagnostakos, K., Grzega, C., Sahan, I., Geipel, U. & Becker, S. L. Occurrence of rare pathogens at the site of periprosthetic hip and knee joint infections: a retrospective, single-center study. Antibiotics 10, 882 (2021).","DOI":"10.3390\/antibiotics10070882"},{"key":"61426_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijid.2016.10.006","volume":"53","author":"P Basu","year":"2016","unstructured":"Basu, P., Williams, A., O\u2019Brien, M. T., Brouns, M. & Edwards, P. A case of Finegoldia magna (formerly Peptostreptococcus magnus) infection mimicking disseminated malignancy. Int. J. Infect. Dis. 53, 12\u201314 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"61426_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.anaerobe.2017.05.011","volume":"47","author":"SH Hosseini Dehkordi","year":"2017","unstructured":"Hosseini Dehkordi, S. H. & Osorio, G. Case of pacemaker pocket infection caused by Finegoldia magna. Anaerobe 47, 135\u2013136 (2017).","journal-title":"Anaerobe"},{"key":"61426_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2022.102666","volume":"78","author":"EM Parisio","year":"2022","unstructured":"Parisio, E. M. et al. Epidemiology and antibiotic susceptibility profiles of obligate anaerobes in a hospital of central Italy during a one-year (2019) survey. Anaerobe 78, 102666 (2022).","journal-title":"Anaerobe"},{"key":"61426_CR38","first-page":"966","volume":"218","author":"CA Muzny","year":"2018","unstructured":"Muzny, C. A. et al. Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study. J. Infect. Dis. 218, 966\u2013978 (2018).","journal-title":"J. Infect. Dis."},{"key":"61426_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmicb.2020.00065","volume":"11","author":"A Neumann","year":"2020","unstructured":"Neumann, A., Bjorck, L. & Frick, I. M. Finegoldia magna, an anaerobic gram-positive bacterium of the normal human microbiota, induces inflammation by activating neutrophils. Front. Microbiol. 11, 65 (2020).","journal-title":"Front. Microbiol."},{"key":"61426_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51142-8","volume":"9","author":"RR Cook","year":"2019","unstructured":"Cook, R. R. et al. Alterations to the gastrointestinal microbiome associated with methamphetamine use among young men who have sex with men. Sci. Rep. 9, 14840 (2019).","journal-title":"Sci. Rep."},{"key":"61426_CR41","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1128\/AEM.02810-10","volume":"77","author":"PD Schloss","year":"2011","unstructured":"Schloss, P. D. & Westcott, S. L. Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis. Appl. Environ. Microbiol. 77, 3219\u20133226 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"61426_CR42","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"61426_CR43","doi-asserted-by":"publisher","first-page":"D633","DOI":"10.1093\/nar\/gkt1244","volume":"42","author":"JR Cole","year":"2014","unstructured":"Cole, J. R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633\u2013D642 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61426-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:39:30Z","timestamp":1751564370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61426-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61426"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61426-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6143"}}